John Andriulli, DO
Cardiovascular Disease · Camden, NJNPI 1225063324
Payments from drug & device makers
Across 407 payments — averaging $272.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$79K
- Biosense Webster, Inc.$14K
- Medtronic$7K
- Cook Incorporated$4K
- Medical Device Business Services, Inc.$3K
- Johnson & Johnson$1K
- plus $2K from 22 others
What the payments were for
- Consulting fees$69,16962%
- Speaking & faculty fees$20,52119%
- Travel & lodging$12,69611%
- Food & beverage$8,4158%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 129 | $79,421 |
| Biosense Webster, Inc. | 16 | $14,202 |
| Medtronic(2 entities) | 53 | $6,692 |
| Cook Incorporated | 1 | $3,560 |
| Medical Device Business Services, Inc. | 6 | $3,261 |
| Johnson & Johnson(2 entities) | 119 | $1,357 |
| Atricure, Inc. | 24 | $856 |
| Boston Scientific | 9 | $200 |
| Stryker | 3 | $165 |
| Abbott | 2 | $154 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $150 |
| Novartis | 10 | $136 |
| Bard Access Systems, Inc. | 1 | $127 |
| Cook Medical LLC | 1 | $96 |
| Pfizer | 5 | $61 |
| E.r. Squibb & Sons, L.L.C. | 4 | $54 |
| Amgen | 3 | $52 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| Abiomed | 2 | $29 |
| Inari Medical, Inc. | 1 | $29 |
| Impulse Dynamics (USA) Inc. | 1 | $28 |
| Cvrx, Inc. | 1 | $28 |
| Vital Connect, Inc | 1 | $25 |
| Angiodynamics, Inc. | 1 | $22 |
| Medicomp Inc | 1 | $20 |
| Altathera Pharmaceuticals LLC | 1 | $17 |
| Mirum Pharmaceuticals, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$44,715
- Carto 3$13,732
- (5028) IGT Devices Systems Undivided$8,421
- (9124) LM Undivided$6,248
- Spectranetics Undiv$5,500
- CVX-300$5,302
- IGT D Peripheral$4,000
- Evolution$3,560
- STRATAFIX$2,876
- DERMABOND$2,525
- Stellarex$2,400
- EVERA MRI XT DR SURESCAN$2,137
- Carto 3 System$736
- Bridge$467
- IGT Devices Und$287
- Surgicel Powder$242
- LLD$239
- VISTASEAL$230
- Micra$159
- ARTIX MT$133
How this compares
$110,801 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 88 | $98,981 |
| XareltoRivaroxaban | 63 | $67,759 |
| Metoprolol Succinate | 163 | $3,268 |
| Dofetilide | 14 | $2,755 |
| Amiodarone Hcl | 64 | $1,919 |
| Flecainide Acetate | 15 | $1,044 |
| SotalolSotalol Hcl | 26 | $557 |
| Atorvastatin Calcium | 37 | $396 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $380 |
| Carvedilol | 29 | $332 |
| Metoprolol Tartrate | 28 | $248 |
| Amlodipine Besylate | 36 | $220 |
| Rosuvastatin Calcium | 12 | $101 |
| Furosemide | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $61 | $98,98188 claims |
| Johnson & JohnsonXarelto | $1,357 | $67,75963 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in Camden
- Sajjad SabirCamden$742K
- Andrea RussoCamden$415K
- Perry WeinstockCamden$178K
- Robert KippermanMorristown$5.3M
- Sharan MahalBridgewater$3.5M
- Linda GillamMorristown$2.2M
- Mark GelerntHaddon Heights$2M
- Robert FishbergSpringfield$1.9M
- Dilip ViswanathHaddon Heights$1.8M
- Marc CohenNewark$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.